These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 29491063)
1. Suppressive Effect of Delta-Tocotrienol on Hypoxia Adaptation of Prostate Cancer Stem-like Cells. Kaneko S; Sato C; Shiozawa N; Sato A; Sato H; Virgona N; Yano T Anticancer Res; 2018 Mar; 38(3):1391-1399. PubMed ID: 29491063 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of a redox-silent analogue of tocotrienol on hypoxia adaptation in prostate cancer cells. Shiozawa N; Sugahara R; Namiki K; Sato C; Ando A; Sato A; Virgona N; Yano T Anticancer Drugs; 2017 Mar; 28(3):289-297. PubMed ID: 27926612 [TBL] [Abstract][Full Text] [Related]
3. The role of hypoxia-inducible factor-1α and -2α in androgen insensitive prostate cancer cells. Jeong CW; Yoon CY; Jeong SJ; Hong SK; Byun SS; Kwak C; Lee SE Urol Oncol; 2013 Nov; 31(8):1448-56. PubMed ID: 22537539 [TBL] [Abstract][Full Text] [Related]
4. Gamma-tocotrienol as an effective agent in targeting prostate cancer stem cell-like population. Luk SU; Yap WN; Chiu YT; Lee DT; Ma S; Lee TK; Vasireddy RS; Wong YC; Ching YP; Nelson C; Yap YL; Ling MT Int J Cancer; 2011 May; 128(9):2182-91. PubMed ID: 20617516 [TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer. Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133 [TBL] [Abstract][Full Text] [Related]
6. Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells. Palayoor ST; Tofilon PJ; Coleman CN Clin Cancer Res; 2003 Aug; 9(8):3150-7. PubMed ID: 12912967 [TBL] [Abstract][Full Text] [Related]
7. Annatto Tocotrienol Induces a Cytotoxic Effect on Human Prostate Cancer PC3 Cells via the Simultaneous Inhibition of Src and Stat3. Sugahara R; Sato A; Uchida A; Shiozawa S; Sato C; Virgona N; Yano T J Nutr Sci Vitaminol (Tokyo); 2015; 61(6):497-501. PubMed ID: 26875492 [TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells. Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267 [TBL] [Abstract][Full Text] [Related]
9. Everolimus (RAD001) sensitizes prostate cancer cells to docetaxel by down-regulation of HIF-1α and sphingosine kinase 1. Alshaker H; Wang Q; Kawano Y; Arafat T; Böhler T; Winkler M; Cooper C; Pchejetski D Oncotarget; 2016 Dec; 7(49):80943-80956. PubMed ID: 27821815 [TBL] [Abstract][Full Text] [Related]
10. Multimodal targeting of tumor vasculature and cancer stem-like cells in sarcomas with VEGF-A inhibition, HIF-1α inhibition, and hypoxia-activated chemotherapy. Yoon C; Chang KK; Lee JH; Tap WD; Hart CP; Simon MC; Yoon SS Oncotarget; 2016 Jul; 7(28):42844-42858. PubMed ID: 27374091 [TBL] [Abstract][Full Text] [Related]
11. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition. Iannelli F; Roca MS; Lombardi R; Ciardiello C; Grumetti L; De Rienzo S; Moccia T; Vitagliano C; Sorice A; Costantini S; Milone MR; Pucci B; Leone A; Di Gennaro E; Mancini R; Ciliberto G; Bruzzese F; Budillon A J Exp Clin Cancer Res; 2020 Oct; 39(1):213. PubMed ID: 33032653 [TBL] [Abstract][Full Text] [Related]
12. The marine-derived HIF-1α inhibitor, Yardenone 2, reduces prostate cancer cell proliferation by targeting HIF-1 target genes. Peng S; Guo Y; Irondelle M; Mazzu A; Kahi M; Ferreira Montenegro P; Bost F; Mazure NM Cell Mol Biol Lett; 2024 Jul; 29(1):101. PubMed ID: 38978018 [TBL] [Abstract][Full Text] [Related]
14. Combined treatment targeting HIF-1α and Stat3 is a potent strategy for prostate cancer therapy. Reddy KR; Guan Y; Qin G; Zhou Z; Jing N Prostate; 2011 Dec; 71(16):1796-809. PubMed ID: 21480310 [TBL] [Abstract][Full Text] [Related]
15. Alpha-tocopheryl succinate (alpha-TOS) modulates human prostate LNCaP xenograft growth and gene expression in BALB/c nude mice fed two levels of dietary soybean oil. Basu A; Grossie B; Bennett M; Mills N; Imrhan V Eur J Nutr; 2007 Feb; 46(1):34-43. PubMed ID: 17180484 [TBL] [Abstract][Full Text] [Related]
16. Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions. Chae KS; Kang MJ; Lee JH; Ryu BK; Lee MG; Her NG; Ha TK; Han J; Kim YK; Chi SG Oncogene; 2011 Mar; 30(10):1213-28. PubMed ID: 21057546 [TBL] [Abstract][Full Text] [Related]
17. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells. Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944 [TBL] [Abstract][Full Text] [Related]
18. Ursolic acid inhibits proliferation and reverses drug resistance of ovarian cancer stem cells by downregulating ABCG2 through suppressing the expression of hypoxia-inducible factor-1α in vitro. Wang WJ; Sui H; Qi C; Li Q; Zhang J; Wu SF; Mei MZ; Lu YY; Wan YT; Chang H; Guo PT Oncol Rep; 2016 Jul; 36(1):428-40. PubMed ID: 27221674 [TBL] [Abstract][Full Text] [Related]
19. Atorvastatin enhances radiosensitivity in hypoxia-induced prostate cancer cells related with HIF-1α inhibition. Chen B; Zhang M; Xing D; Feng Y Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28760843 [TBL] [Abstract][Full Text] [Related]
20. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia. Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]